Vivos Therapeutics, Inc.VVOSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-13.26M
↓ 12% below average
Average (6y)
$-11.79M
Historical baseline
Range
High:$-5.52M
Low:$-20.51M
CAGR
+12.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-13.26M | -4.0% |
| 2023 | $-12.75M | +37.8% |
| 2022 | $-20.51M | -13.1% |
| 2021 | $-18.13M | -212.6% |
| 2020 | $-5.80M | -5.2% |
| 2019 | $-5.52M | +16.0% |
| 2018 | $-6.56M | - |